# ZYPREXA
> **NDA021253** · New Drug Application · Sponsor: CHEPLAPHARM · Approved 2004-03-29
## Drug
- **FDA Application Number:** NDA021253
- **Application type:** New Drug Application
- **Brand name:** ZYPREXA
- **Generic name:** OLANZAPINE
- **Active ingredients:** OLANZAPINE
- **Dosage form:** POWDER
- **Route:** INTRAMUSCULAR
- **Marketing status:** Prescription
- **Sponsor:** CHEPLAPHARM
- **Manufacturer:** Eli Lilly and Company
- **First approval:** 2004-03-29
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021253)
---
*MORVS · CC0 1.0*